Long-term survival of patients with hepatocellular carcinoma with pulmonary and adrenal metastasis: A case report

Zhang,H. Y.; Wu,Q. J.; Xie,C. H.; Zhang,G.

doi:10.3892/etm.2012.455

Long-term survival of patients with hepatocellular carcinoma with pulmonary and adrenal metastasis: A case report

Authors:
- H. Y. Zhang
- Q. J. Wu
- C. H. Xie
- G. Zhang
View Affiliations

Affiliations: Hubei Cancer Clinical Study Center, Department of Radiochemotherapy, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China, Hubei Cancer Clinical Study Center, Department of Radiochemotherapy, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: January 16, 2012 https://doi.org/10.3892/etm.2012.455
Pages: 699-702

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver, and has a poor prognosis. In this study, we reported an exceptional clinical case of primary HCC with metastatic disease in the lungs 1 year following hepatic resection, and in the left adrenal gland 8 years following hepatic resection. Comprehensive treatments, including partial hepatic resection, systemic chemotherapies with various regimens, such as radiotherapy, were administered to this patient. In this case, there was no intrahepatic recurrence of the malignancy and the metastatic disease was sensitive to chemotherapy and radiotherapy. The patient remained alive and in good health for 10 years following the diagnosis of HCC despite early metastatic disease. This indicates that for certain patients with advanced stage HCC, palliative treatments may still be beneficial to their survival. We also discussed the advance in recent research into HCC treatment.

View Figures

View References

1.	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2.	Okuda K: Hepatocellular carcinoma. J Hepatol. 32:225–237. 2000. View Article : Google Scholar
3.	Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
4.	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
5.	Raza SA, Clifford GM and Franceschi S: Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer. 96:1127–1134. 2007. View Article : Google Scholar : PubMed/NCBI
6.	Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 118:3030–3044. 2006.PubMed/NCBI
7.	Katyal S, Oliver JR, Peterson MS, Ferris JV, Carr BS and Baron RL: Extrahepatic metastases of hepatocellular carcinoma. Radiology. 216:698–703. 2000. View Article : Google Scholar : PubMed/NCBI
8.	Kummar S and Shafi NQ: Metastatic hepatocellular carcinoma. Clin Oncol (R Coll Radiol). 15:288–294. 2003. View Article : Google Scholar
9.	Lopez PM, Villanueva A and Llovet JM: Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials. Aliment Pharmacol Ther. 23:1535–1547. 2006. View Article : Google Scholar : PubMed/NCBI
10.	Belghiti J, Cortes A, Abdalla EK, Régimbeau JM, Prakash K, Durand F, Sommacale D, Dondero F, Lesurtel M, Sauvanet A, Farges O and Kianmanesh R: Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 238:885–893. 2003. View Article : Google Scholar : PubMed/NCBI
11.	Ikai I, Itai Y, Okita K, Omata M, Kojiro M, Kobayashi K, Nakanuma Y, Futagawa S, Makuuchi M and Yamaoka Y: Report of the 15th follow-up survey of primary liver cancer. Hepatol Res. 28:21–29. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A and Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 334:693–699. 1996. View Article : Google Scholar : PubMed/NCBI
13.	Lai EC and Lau WY: The continuing challenge of hepatic cancer in Asia. Surgeon. 3:210–215. 2005. View Article : Google Scholar : PubMed/NCBI
14.	Urabe T, Kaneko S, Matsushita E, Unoura M and Kobayashi K: Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma. Oncology. 55:39–47. 1998. View Article : Google Scholar
15.	Zhu AX, Blaszkowsky LS, Ryan DP, Clark JW, Muzikansky A, Horgan K, Sheehan S, Hale KE, Enzinger PC, Bhargava P and Stuart K: Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma. J Clin Oncol. 24:1898–1903. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Hotte SJ, Hirte HW, Chen EX, Siu LL, Le LH, Corey A, Iacobucci A, MacLean M, Lo L, Fox NL and Oza AM: A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies. Clin Cancer Res. 14:3450–3455. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Clark-Garvey S, Weinberg A, Mandeli J, et al: Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 26:2992–2998. 2008. View Article : Google Scholar : PubMed/NCBI
18.	Thomas MB, Chadha R, Glover K, Wang X, Morris J, Brown T, Rashid A, Dancey J and Abbruzzese JL: Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer. 110:1059–1067. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Shirabe K, Kitamura M, Tsutsui S, Maeda T, Matsumata T and Sugimachi K: A long-term survivor of ruptured hepatocellular carcinoma after hepatic resection. J Gastroenterol Hepatol. 10:351–354. 1995. View Article : Google Scholar : PubMed/NCBI
20.	Schreibman IR, Bejarano P, Martinez EJ and Regev A: Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review. Transplant Proc. 38:3140–3143. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Zhou XD, Tang ZY, Ma ZC, Fan J, Wu ZQ, Qin LX, Zhou J, Yu Y, Sun HC and Qiu SJ: Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases. J Cancer Res Clin Oncol. 135:1067–1072. 2009.PubMed/NCBI